Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 35

1.

Clinico-pathological prognostic factors of renal cell carcinoma: A 15-year review from a single center in Greece.

Grivas N, Kafarakis V, Tsimaris I, Raptis P, Hastazeris K, Stavropoulos NE.

Urol Ann. 2014 Apr;6(2):116-21. doi: 10.4103/0974-7796.130552.

2.

Efficacy of postoperative bladder irrigation with water for injection in reducing recurrence rates of non muscle invasive bladder cancer.

Grivas N, Hastazeris K, Kafarakis V, Tsimaris I, Aspiotis S, Stratis A, Stavropoulos NE.

Asian Pac J Cancer Prev. 2014;15(5):2263-6.

3.
4.

Follicular thyroid cancer metastasis to the urinary bladder: report of a case and review of the literature.

Grivas N, Housianitis Z, Doukas M, Stavropoulos NE.

Case Rep Urol. 2012;2012:178915. doi: 10.1155/2012/178915. Epub 2012 Aug 1.

5.

Prostate cancer epidemiology in a rural area of North Western Greece.

Grivas N, Hastazeris K, Kafarakis V, Tsimaris I, Xousianitis Z, Makatsori A, Raptis P, Aspiotis S, Ioachim E, Ntemou A, Kitsiou E, Malamou-Mitsi V, Sofikitis N, Kordela V, Papandreou C, Agnantis NJ, Stavropoulos NE.

Asian Pac J Cancer Prev. 2012;13(3):999-1002.

6.

Hematuria secondary to an internal iliac artery aneurysm.

Makatsori A, Stavropoulos NE.

Korean J Urol. 2010 Aug;51(8):583-5. doi: 10.4111/kju.2010.51.8.583. Epub 2010 Aug 18.

7.

Radical therapy for muscle-infiltrating bladder cancer (cystectomy or radiotherapy): does age affect the final therapeutic benefit for the patient?

Kalogeras D, Lampri E, Goussia A, Bai M, Capizzello A, Tassiou I, Stavropoulos NE, Tsekeris P.

J BUON. 2008 Jul-Sep;13(3):353-8.

8.

Immunohistochemical prognostic markers in bladder cancer.

Ioachim E, Stavropoulos NE, Charalabopoulos K, Agnantis NJ.

J BUON. 2002 Jul-Sep;7(3):207-16.

9.

Hypoxia-inducible factors HIF-1alpha and HIF-2alpha expression in bladder cancer and their associations with other angiogenesis-related proteins.

Ioachim E, Michael M, Salmas M, Michael MM, Stavropoulos NE, Malamou-Mitsi V.

Urol Int. 2006;77(3):255-63.

PMID:
17033215
10.

Thrombospondin-1 expression in urothelial carcinoma: prognostic significance and association with p53 alterations, tumour angiogenesis and extracellular matrix components.

Ioachim E, Michael MC, Salmas M, Damala K, Tsanou E, Michael MM, Malamou-Mitsi V, Stavropoulos NE.

BMC Cancer. 2006 May 29;6:140.

11.

Hypericum perforatum L. extract - novel photosensitizer against human bladder cancer cells.

Stavropoulos NE, Kim A, Nseyo UU, Tsimaris I, Chung TD, Miller TA, Redlak M, Nseyo UO, Skalkos D.

J Photochem Photobiol B. 2006 Jul 3;84(1):64-9. Epub 2006 Mar 15.

PMID:
16540336
12.

The lipophilic extract of Hypericum perforatum exerts significant cytotoxic activity against T24 and NBT-II urinary bladder tumor cells.

Skalkos D, Stavropoulos NE, Tsimaris I, Gioti E, Stalikas CD, Nseyo UO, Ioachim E, Agnantis NJ.

Planta Med. 2005 Nov;71(11):1030-5.

PMID:
16320204
13.

Prognostic significance of thymidine phosphorylase in superficial bladder carcinoma.

Stavropoulos NE, Bouropoulos C, Ioachim E, Michael M, Hastazeris K, Tsimaris I, Kalogeras D, Liamis Z, Kafarakis V, Stefanaki S, Malamou-Mitsi V.

Int Urol Nephrol. 2005;37(1):55-60.

PMID:
16132760
14.

A clinicopathological study of the expression of extracellular matrix components in urothelial carcinoma.

Ioachim E, Michael M, Stavropoulos NE, Kitsiou E, Salmas M, Malamou-Mitsi V.

BJU Int. 2005 Mar;95(4):655-9.

15.

Prognostic significance of angiogenesis in superficial bladder cancer.

Stavropoulos NE, Bouropoulos C, Ioachim IE, Michael M, Hastazeris K, Tsimaris I, Kalogeras D, Liamis Z, Stefanaki S, Agnantis NI.

Int Urol Nephrol. 2004;36(2):163-7.

PMID:
15368686
17.

Simultaneous adenomectomy and preperitoneal repair of inguinal hernias by a single incision with the application of polypropylene mesh.

Filiadis I, Hastazeris K, Tsimaris I, Papadopoulos A, Kakoulidis S, Stavropoulos NE.

Int Urol Nephrol. 2003;35(1):19-24.

PMID:
14620277
18.

Prognostic significance of p53, bcl-2 and Ki-67 in high risk superficial bladder cancer.

Stavropoulos NE, Filiadis I, Ioachim E, Hastazeris K, Tsimaris I, Kalogeras D, Stefanaki S, Agnantis NJ.

Anticancer Res. 2002 Nov-Dec;22(6B):3759-64.

PMID:
12552989
19.

CD44 standard form expression as a predictor of progression in high risk superficial bladder tumors.

Stavropoulos NE, Filliadis I, Ioachim E, Michael M, Mermiga E, Hastazeris K, Nseyo UO.

Int Urol Nephrol. 2001;33(3):479-83.

PMID:
12230276
20.

Intravesical instillations of interferon gamma in the prophylaxis of high risk superficial bladder cancer--results of a controlled prospective study.

Stavropoulos NE, Hastazeris K, Filiadis I, Mihailidis I, Ioachim E, Liamis Z, Kalomiris P.

Scand J Urol Nephrol. 2002;36(3):218-22.

PMID:
12201939

Supplemental Content

Loading ...
Support Center